Tag: Scott Millard

Clinical Research: Phase 1 - Phase 4

Premier Voices #3: The Placebo Problem Part 1 With Scott Millard

 The placebo effect’s impact on drug development is widely known, but you may be surprised to learn that the word “placebo” has had multiple meanings — all of them pejorative — going back hundreds of years. Scott Millard, Premier Research’s Executive Director for Strategic Development and Analgesia, explores the role of placebos in the...

Clinical Research: Phase 1 - Phase 4

Chronic Pain: Conducting Clinical Trials In Osteoarthritis

It’s the leading cause of disability due to pain and the most common form of arthritis, afflicting an estimated 237 million people worldwide. Osteoarthritis (OA) occurs as the cartilage on the end of bones wears down and most often affects the hands, knees, hips, and spine – though it can damage any joint in the...